Novavax price target lowered to $12 from $14 at BofA
BofA lowered the firm’s price target on Novavax (NVAX) to $12 from $14 and keeps a Neutral rating on the shares. The company announced ...
The Globe and Mail35m
S&P Futures Tick Lower as Key U.S. Inflation Data Looms
Rocket Lab USA (RKLB) soared about +26% in pre-market trading after the company posted better-than-expected Q3 results and issued above-consensus Q4 revenue guidance. Rivian Automotive (RIVN) surged ...